Go Asia life sciences
What is Go Asia life sciences?
Go Asia Life Sciences is designed to help life science companies tap into the vast market opportunities available in Asia, including cutting edge medical devices, precision medicine, immunotherapy, synthetic biology and agritech. With the region’s booming healthcare and life sciences sectors, expanding your business into Asia is a strategic move that can unlock tremendous growth potential.
By joining Go Asia life sciences, you’ll gain a competitive edge in Asia, capitalise on emerging trends and tap into the region’s rapidly growing life sciences industry. Whether you aim to expand your sales, establish research collaborations or set up local manufacturing facilities, our program is your gateway to success in Asia. Each programme combines training, market research, individual consultations, matchmaking and soft-landing assistance to give you a running start in Asia.Â
What do the programmes involve?
Coaching
Mentoring from world-leading scale coaches; helping your teams scale and develop support networks beyond our free, selective, Go Asia programmes. Transition from the development phase of your venture to registering a company, setting up bank accounts, building the team, dealing with admin and start trading.
Training
Founder and c-suite sessions designed to tackle fundamental growth barriers, real business challenges and risks. Hear from the business experts who have settled in Asia and founders who have been through it all. Group visits to Asia for companies and experts and in the opposite direction for governmental officials and representatives of larger companies.
Matchmaking
Identify potential clients, build partnerships, expand your network and join the ecosystem. Connect to industry leaders, academic partners, gov agencies and the investment community to propel your business into the new development stage. Pitch your solutions to potential investors and ecosystem players.Â
Experts
Nathan McNally
• Led multimillion-pound European initiatives supporting tech entrepreneurs for the last 10 years.
• Health & Life Science Director at Capital Enterprise putting in place enterprise support for health and life science.
• Over the last 10 years stimulating £2+ billion in private SME investment creating 2000+ jobs.
• Co-founded P4 Precision Medicine Accelerator in 2019, for AI enabled precision medicine companies.
• Brings together key stakeholders and decision makers to improve precision medicine.
Dr. John Collins
• Former Operations & Commercial Director at Imperial College’s Synthetic Biology start-up facility.
• Portfolio career includes R&D, product development, technical sales, international business development, and NED for a biotech & medical imaging companies.
• Supports a wide variety of start-ups, providing business and entrepreneurship training globally.
• Runs Innovation Foundry Ltd., a disruptive technologies & innovations management consultancy.
• Advices a wide range of hi-tech companies from biotechnology to lab-grown meat to AI.
Xin Xiaoxiong
• Former Operations & Commercial Director at Imperial College’s Synthetic Biology start-up facility.
• Director of the Medical Policy Research Center of Beijing Health Promotion Association.
• Secretary-General of the Special Committee on Pharmaceutical Economy and Comprehensive Evaluation.
• Responsible for policy and market access project research.
• Participated in the investment of the fund (Rongan Venture Capital) initiated by the Beijing Health Promotion Association.
Luo Shizhong
• Secretary General of international professional committee of China Pharmaceutical Enterprise Management Association.
• General Manager of AnJin Biotechnology Co., Ltd.
• He has 21 years of experiences of the international business development in the pharmaceutical industry.
• Has managed more than 10 global transaction deals with the models of IP license-in, JV and distribution rights granting.
